| Size & multiples | |||
| Market Cap | SEK 33.2M | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 0.56× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | −640.46% | Buyback Yield | — |
| Owner Earnings (TTM) | -SEK 185.2M | Owner Earnings Yield | −558.25% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 2.25 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 15.23% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
Flows latest annual · EPS TTM -SEK 0.32 · revenue TTM SEK 59.7M · FCF TTM -SEK 212.4M (in SEK)
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -640.5% | -7.8% | -34.7%–1.4% | 2 ↓weak |
| Net Margin | -391.7% | -21.2% | -325.3%–7.2% | 23 ↓weak |
| Operating Margin | -383.7% | -34.5% | -552.0%–8.0% | 27 ↓weak |
